RCM
COLL icon

RA Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

RA Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-486,557
Closed -$8.83M – 36
2016
Q1 		$8.83M Sell
486,557
-371,126
-43% -$6.75M 1.13% 25
2015
Q4 		$23.6M Sell
857,683
-695,492
-45% -$14.7M 2.33% 13
2015
Q3 		$34.3M Buy
1,553,175
+7,765
+0.5% +$140K 4.93% 4
2015
Q2 		$27.6M Buy
+1,545,410
New +$26.7M 2.77% 11

Other funds holding COLL

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RA Capital Management's COLL Position: Q2 2016 in Review

RA Capital Management sold out of Collegium Pharmaceutical (COLL) in Q2 2016, closing a stake of 486,557 shares — an estimated $8.83M sold.

RA Capital Management first reported a position in COLL in Q2 2015 and held it in 4 quarters. The position peaked at $34.3M in Q3 2015. 73 funds tracked by Wall St. Rank hold COLL as of Q2 2016.

  • RA Capital Management reported no remaining Collegium Pharmaceutical position as of Q2 2016 after selling out during the quarter.
  • RA Capital Management sold 486,557 Collegium Pharmaceutical shares in Q2 2016, an estimated $8.83M.
  • RA Capital Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 4 quarters.
  • RA Capital Management's Collegium Pharmaceutical position peaked at $34.3M in Q3 2015.
  • 73 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2016.

Based on RA Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.